Invizyne Technologies Inc/$EXOZ
1D1W1MYTD1Y5YMAX
Capital at risk
About Invizyne Technologies Inc
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
- Ticker
- $EXOZ
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Monrovia, United States
- Website
- www.exozymes.com
EXOZ Metrics
BasicAdvanced
$60M
-
-$1.20
-
-
Price and volume
Market cap
$60M
52-week high
$18.40
52-week low
$4.35
Average daily volume
6.1K
Financial strength
Current ratio
3.813
Quick ratio
3.63
Long term debt to equity
0.203
Total debt to equity
0.297
Profitability
EBITDA (TTM)
-10.262
Effective tax rate (TTM)
1.02%
Management effectiveness
Return on assets (TTM)
-74.74%
Return on equity (TTM)
-187.16%
Valuation
Price to book
16.34
Price to tangible book (TTM)
16.34
Price to free cash flow (TTM)
-7.639
Free cash flow yield (TTM)
-13.09%
Free cash flow per share (TTM)
-0.842
Growth
Earnings per share change (TTM)
18.90%
Upcoming events
No upcoming events
EXOZ News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.